These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 7430360)

  • 21. [Clinical relevance of immunoglobulin M antibody fraction against hepatitis B core antigen (anti-HBc-IgM) (author's transl)].
    Feuerhake A; Wille E; Müller R
    Dtsch Med Wochenschr; 1982 Jul; 107(26):1012-4. PubMed ID: 7084068
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Anti-core antibody in HBsAg negative subjects].
    Ferroni P; Quartodipalo ME; Zanetti AR
    Boll Ist Sieroter Milan; 1978 Nov; 57(5):676-9. PubMed ID: 556542
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serologic markers of hepatitis B and A infections in the healthy population.
    Sabău M; Kiss E; Muntean I; Căpîlnă E
    Virologie; 1983; 34(3):197-201. PubMed ID: 6636535
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibody to hepatitis B core antigen in chronic active hepatitis.
    Bories P; Coursaget P; Goudeau A; Degott C; Maupas P; Benhamou JP
    Br Med J; 1978 Feb; 1(6110):396-7. PubMed ID: 624027
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of hepatitis-B virus markers in multi-transfused thalassemic patients.
    Mital MK; Vij JC; Talukdar B; Sachdev HP; Saini L
    Indian Pediatr; 1988 Feb; 25(2):161-5. PubMed ID: 3246395
    [No Abstract]   [Full Text] [Related]  

  • 26. Prevalence of hepatitis A and B infections in multiply transfused thalassaemic patients.
    Papaevangelou G; Frösner G; Economidou J; Parcha S; Roumeliotou A
    Br Med J; 1978 Mar; 1(6114):689-91. PubMed ID: 630296
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [HBsAg and anti-HBs in thalassemia non-transfused patients (and in their relatives)].
    Tannoia N; Putignano A; Cenci I; Colasuonno G; Dimonte D; Petrozzi L; Pastore G
    Boll Ist Sieroter Milan; 1978 May; 57(2):208-11. PubMed ID: 728269
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatitis B and A markers in children with thalassaemia and sickle-cell disease in Riyadh.
    Babiker MA; Bahakim HM; el-Hazmi MA
    Ann Trop Paediatr; 1986 Mar; 6(1):59-62. PubMed ID: 2428295
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatitis B virus DNA-positive, hepatitis B surface antigen-negative blood donations intercepted by anti-hepatitis B core antigen testing: the Canadian Blood Services experience.
    O'Brien SF; Fearon MA; Yi QL; Fan W; Scalia V; Muntz IR; Vamvakas EC
    Transfusion; 2007 Oct; 47(10):1809-15. PubMed ID: 17880605
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Investigation of the presence of HBV-DNA in isolated anti-HBc positive cases and their importance in blood banking].
    Bal SH; Heper Y; Kumaş LT; Mistik R; Töre O
    Mikrobiyol Bul; 2009 Apr; 43(2):243-50. PubMed ID: 19621609
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A sero-epidemiological cross-sectional study of hepatitis B virus in Zimbabwe.
    Tswana S; Chetsanga C; Nyström L; Moyo S; Nzara M; Chieza L
    S Afr Med J; 1996 Jan; 86(1):72-5. PubMed ID: 8685787
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Occult hepatitis B virus infection among Iranian blood donors: a preliminary study.
    Alizadeh Z; Milani S; Sharifi Z
    Arch Iran Med; 2014 Feb; 17(2):106-7. PubMed ID: 24527970
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Presence of Hepatitis B Surface Antibody in Addition to Hepatitis B Core Antibody Confers Protection Against Hepatitis B Virus Infection in Hepatitis B Surface Antigen-negative Patients Undergoing Kidney Transplantation.
    Jeon JW; Kim SM; Cho H; Baek CH; Kim H; Shin S; Kim YH; Han DJ; Kim SB
    Transplantation; 2018 Oct; 102(10):1717-1723. PubMed ID: 29621059
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evidence for hepatitis B and other virus infection in HBsAg-negative chronic active hepatitis.
    Villa E; Jenkins P; Portmann B; Eddleston AL; Williams R
    Dig Dis Sci; 1980 May; 25(5):347-52. PubMed ID: 6768535
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatitis B core antigen immune complexes in the liver of hepatitis B patients.
    Ray MB; Desmet VJ; Bradburne AF; Desmyter J; Fevery J; De Groote J
    Clin Exp Immunol; 1979 Jul; 37(1):15-24. PubMed ID: 385186
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatitis B viral markers in patients with primary hepatocellular carcinoma in Taiwan.
    Chien MC; Tong MJ; Lo KJ; Lee JK; Milich DR; Vyas GN; Murphy BL
    J Natl Cancer Inst; 1981 Mar; 66(3):475-9. PubMed ID: 6162990
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatitis B viral markers in surface antigen negative blood donors: the need to look beyond antibody negativity.
    Salawu L; Adegoke AO; Aboderin AO; Huraina HA
    West Afr J Med; 2011; 30(4):292-5. PubMed ID: 22669836
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Significance of screening antibodies to hepatitis B virus core antigen among Syrian blood donors.
    Muselmani W; Habbal W; Monem F
    Transfus Med; 2013 Aug; 23(4):265-8. PubMed ID: 23621787
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Type B hepatitis after transfusion with blood containing antibody to hepatitis B core antigen.
    Hoofnagle JH; Seeff LB; Bales ZB; Zimmerman HJ
    N Engl J Med; 1978 Jun; 298(25):1379-83. PubMed ID: 652005
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Universal infant immunization and occult hepatitis B virus infection in children and adolescents: a population-based study.
    Hsu HY; Chang MH; Ni YH; Chiang CL; Wu JF; Chen HL
    Hepatology; 2015 Apr; 61(4):1183-91. PubMed ID: 25501911
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.